Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.
about
AL amyloidosis manifesting as systemic lymphadenopathy.Changes in serum-free light chain rather than intact monoclonal immunoglobulin levels predicts outcome following therapy in primary amyloidosisTrends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Surgical removal of amyloid-laden lymph nodes: a possible therapeutic approach in a primary systemic AL amyloidosis patient with focal lymphadenopathyRituximab therapy in nephrotic syndrome due to AH amyloidosis
P2860
Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@en
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@nl
type
label
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@en
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@nl
prefLabel
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@en
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@nl
P2093
P1433
P1476
Serum levels of free light cha ...... imary systemic AL amyloidosis.
@en
P2093
Kazuo Sakashita
Kenichi Koike
Masayuki Matsuda
Shu-ichi Ikeda
Takahisa Gono
Tomohisa Fushimi
Toshiyuki Yamada
Wataru Ishii
Yasuhiro Shimojima
P304
P356
10.2169/INTERNALMEDICINE.44.428
P577
2005-05-01T00:00:00Z